Literature DB >> 26349988

miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12.

Jian Zhang1, Jing Liu2, Yong Liu3, Weibin Wu1, Xiaojun Li1, Yonghui Wu1, Huiguo Chen1, Kai Zhang1, Lijia Gu4.   

Abstract

Cancer-associated fibroblasts (CAFs) are the main component of tumor stroma which support tumor progression. Here, we set out to determine the factors that may be involved in dramatic alteration of microRNAs (miRNAs) expression pattern in CAFs. miRNAs analyses identified differential expression of 15 microRNAs, with miR-101 being the most downregulated miRNA in CAFs which were different from the normal fibroblasts. We examined several putative miR-101 target genes identified by microarray analysis and demonstrated that miR-101 directly targets CXCL12, which play important roles in CAFs. Overexpression of miR-101 significantly impaired the ability of CAFs to stimulate tumor cell proliferation, sphere formation migration and invasion, and enhanced apoptosis. Further research showed that the cellular biological behavior was regulated by miR-101 targeting CXCL12. These findings provide new insights miR-101 down-regulation in CAFs could inhibit lung cancer proliferation and metastasis via targeting CXCL12.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CAFs; CXCL12; Lung cancer; miR-101

Mesh:

Substances:

Year:  2015        PMID: 26349988     DOI: 10.1016/j.biopha.2015.08.013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

Review 2.  Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.

Authors:  Weiqiang Zhou; Shanchun Guo; Mingli Liu; Matthew E Burow; Guangdi Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

3.  Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression.

Authors:  Dong-Yeon Nam; Je-Keun Rhee
Journal:  Biology (Basel)       Date:  2022-05-21

4.  Retracted Article: SNHG3 promotes proliferation and invasion by regulating the miR-101/ZEB1 axis in breast cancer.

Authors:  Liang Chang; Zhuang Hu; Zhenyu Zhou; Hui Zhang
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

5.  Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.

Authors:  Yuqi Jing; Valery Chavez; Yuguang Ban; Nicolas Acquavella; Doraya El-Ashry; Alexey Pronin; Xi Chen; Jaime R Merchan
Journal:  Mol Cancer Res       Date:  2017-07-05       Impact factor: 5.852

Review 6.  Leveraging epigenetics to enhance the efficacy of immunotherapy.

Authors:  Jonathan D Licht; Richard L Bennett
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

Review 7.  Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.

Authors:  Jamie N Frediani; Muller Fabbri
Journal:  Mol Cancer       Date:  2016-05-26       Impact factor: 27.401

Review 8.  Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment.

Authors:  Maren Schoepp; Anda Jana Ströse; Jörg Haier
Journal:  Cancers (Basel)       Date:  2017-05-24       Impact factor: 6.639

Review 9.  CXCL12 Signaling in the Tumor Microenvironment.

Authors:  Luigi Portella; Anna Maria Bello; Stefania Scala
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.